Added to YB: 2025-05-26
Pitch date: 2025-03-31
ABBV [bullish]
AbbVie Inc.
+8.76%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.
Market Cap
$394.3B
Pitch Price
$205.33
Price Target
N/A
Dividend
3.10%
EV/EBITDA
15.32
P/E
168.95
EV/Sales
7.67
Sector
Biotechnology
Category
growth
Show full summary:
Renaissance Investment Management Large Cap Growth Strategy New Position: AbbVie Inc.
ABBV (new position): New position in large biopharma co. with stable, profitable business model generating high FCF yield. Growth poised to reaccelerate this year after Humira patent expiration slump. Solid drug pipeline in immunology, virology & oncology offers future growth potential.
Read full article (1 min)